Zhonghua yi xue za zhi
-
Zhonghua yi xue za zhi · Feb 2007
Randomized Controlled Trial Multicenter Study[Clinical trial with a new immunomodulatory strategy: treatment of severe sepsis with Ulinastatin and Maipuxin].
To evaluate the efficacy of treatment of severe sepsis by combining anti-inflammatory and immune-enhancing agents. ⋯ Treatment by the combining anti-inflammatory and immune enhancing agents can significantly improve the outcome of severe sepsis. The efficacy of this therapy seems to be dose dependent on.